Veronica Boland|Emily Stockings|Richard P. Mattick|Hayden McRobbie|Jamie Brown|Ryan J. Courtney
The Methodological Quality and Effectiveness of Technology-Based Smoking Cessation Interventions for Disadvantaged Groups: A Systematic Review and Meta-analysis
UNSW Sydney|UNSW Sydney|UNSW Sydney|Queen Mary University of London|University College London|UNSW Sydney
assess methodological quality effectiveness technologybased smoking cessation interventions disadvantaged groupsfour databases embase cochrane medline psycinfo searched studies conducted 1980 may 2016 randomized controlled trials compared behavioral smoking cessation intervention delivered primarily technologybased platform eg mobile phone nointervention comparison group among disadvantaged smokers included three reviewers assessed relevant studies inclusion one reviewer extracted study participant interventionlevel data subset crosschecked second reviewerthirteen studies targeting disadvantaged smokers n 4820 included one study scored highly terms methodological rigor epoc criteria judging risk bias 13 studies using technologybased platform utilized websites n 5 computer programs n 5 seven additionally offered nicotine replacement therapy technologybased interventions increased odds smoking cessation disadvantaged groups 1 month odds ratio 170 95 confidence interval ci 110 263 3 months 130 95 ci 107 159 6 months 129 95 ci 103 162 18 months postintervention 183 95 ci 111 301few methodologically rigorous studies identified mobile phone textmessaging computer websitedelivered quit support showed promise increasing quit rates among indigenous psychiatric inpatient substance use disorder patients research needed address role technologybased interventions overcoming health inequalities meet needs disadvantaged groupsthis review provides first quantitative evidence effectiveness range technologybased smoking cessation interventions among disadvantaged smokers separate estimates basis intervention type cessation outcome measure providing costeffective easily accessible realtime smoking cessation treatment needed innovative technologybased platforms help reach endpoint interventions need tested larger scale randomized controlled trial designs target broader disadvantaged groups data collection beyond 6 months also needed order establish efficacy intervention approaches longterm cessation rates among disadvantaged population groups